Julio Lau
@drjuliolau
Followers
1K
Following
4K
Media
82
Statuses
2K
Ginecólogo Oncólogo 🇬🇹
Guatemala
Joined January 2012
🎉 We are thrilled to announce that we’ve officially reached 60 graduates of the IGCS Gynecologic Oncology Global Fellowship Program! This milestone represents years of dedication, mentorship, and global collaboration in advancing gynecologic cancer care. A heartfelt thank you
0
3
10
Gran esfuerzo liderado por el Dr Lau y su equipo en el HSJD en Guatemala. El evento contó con una nutrida asistencia de médicos provenientes de países vecinos, destacando la presencia de 15 Ginecólogos Oncólogos y fellows del Salvador. Guatemala se convierte de este manera, en el
Workshop de Cirugías Radicales en vivo de Cáncer Ginecológico. Ciudad de Guatemala. 8 profesores internacionales y 16 nacionales, 8 cirugías oncológicas. Asistencia de cirujanos, ginecólogos y ginecólogos oncólogos de 13 países 🇦🇷🇧🇷🇨🇦🇨🇱🇨🇴🇨🇷🇸🇻🇪🇨🇪🇸🇺🇸🇬🇹🇲🇽🇳🇮
2
5
25
Workshop de Cirugías Radicales en vivo de Cáncer Ginecológico. Ciudad de Guatemala. 8 profesores internacionales y 16 nacionales, 8 cirugías oncológicas. Asistencia de cirujanos, ginecólogos y ginecólogos oncólogos de 13 países 🇦🇷🇧🇷🇨🇦🇨🇱🇨🇴🇨🇷🇸🇻🇪🇨🇪🇸🇺🇸🇬🇹🇲🇽🇳🇮
0
2
22
Just published in The Lancet! ‼️🗞️ ESGO-ESTRO-ESP Guidelines for the Management of Patients with Endometrial Carcinoma: 2025 Update These guidelines are an update from the prior guidelines published in 2021 and cover all relevant aspects of diagnosis, management, follow-up &
1
40
84
#Survey #alert #Gynecology #Oncology practitioner..pl spare 10 mins to contribute to this #global #study @IGCSociety @ESGO_society @SOncology70650 @AGOIofficial @Gyne_Oncology @BGCS_org @ENYGO_official @fogsiofficial @anzgog
https://t.co/JGmaBbBU64
0
19
23
📊 Impact Factor Alert! We’re proud to share that #IJGC's #ImpactFactor has increased to 4.7 in the 2024 Journal Citation Reports! 🚀 💥 We’ve also broken into the #Top10 in #Obstetrics&Gynecology, climbing from #11 to #8 📈 And we moved up 1 spot in #Oncology rankings, too!
7
19
52
Live radical surgery workshop for gynecological cancer. August 18 and 19, 2025. Guatemala City.
0
11
31
✨ Wow! IGCS is incredibly proud of the surgical training impact of the Gynecologic Oncology Global Fellowship Program! 🔪👩⚕️ Fellows are mastering life-saving surgical techniques, improving patient outcomes, and transforming cancer care in their regions. 💙 Here’s to the
1
5
20
🚀 SUROVA is the largest global real-world study on advanced ovarian cancer, and these are its conclusions. #ESGO #SUROVA #OvarianCancer #GlobalStudy #Oncology #RealWorldData
#IGCS
2
16
66
🎉 Since its inception in 2017, IGCS is incredibly proud of the impact and growth of the Gynecologic Oncology Global Fellowship Program! 🌎 Empowering the next generation of cancer care leaders. Learn more here: https://t.co/XEAQKNohWD
0
2
9
The strategic direction of IGCS is guided by three overarching pillars: 1️⃣Enhance Member and Guest Experience 2️⃣Advance Equitable Patient-Centered Care 3️⃣Increase IGCS’ Impact Worldwide Discover how the IGCS flagship mentorship and training program, the Gynecologic Oncology
0
2
3
In this #IJGCconversations episode, @pedroramirezMD discusses "Preoperative tumor size and final pathology in #CervicalCancer" with Dr. Teresa Pan @Pan_Teresa_MD 🎤 https://t.co/xNs7d0LeRM
@HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official
0
6
17
Vaginal Estrogen Use in #breastcancer Survivors: A Systematic Review and Meta-Analysis of Recurrence and Mortality Risks @AJOG_thegray
https://t.co/0TGXjzglA0 No ⬆️ recurrences No ⬆️ mortality ‼️Better #QoL‼️ @OncoAlert @weoncologists @GynMe4 @gyncsm @ESGO_society @IGCSociety
ajog.org
To assess the risk of breast cancer recurrence, breast cancer-specific mortality, and overall mortality for breast cancer survivors receiving vaginal estrogen therapy for genitourinary syndrome of...
1
40
88
🎉 Congratulations on receiving the #IJGC Top Reviewer Award! Thank you for setting the standard of excellence! 👏🤩 #TopReviewerAward #IGCS2024
@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4
0
11
41
#PROMETrial Predicting the risk of #nodal disease in #EndometrialCancer using #histological & #molecular features 🧬 by @BoganiGiorgio 📜 https://t.co/PsF2qUzOT5
@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert
0
17
29
Splenectomy as a part of cytoreductive surgery in #ovariancancer: systematic review and meta-analysis ✅ https://t.co/skrytEsEEv
@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4
0
10
21
Tune in on July 18 while we catch up LIVE with @IJGConline Social Media Editor Dr. @AndreFernandes2 🇻🇪 from Venezuela! 💜 We can’t wait! 📆July 18, 2:30 p.m. GMT -5 (Houston)/ 9:30 p.m. Berlin/ 5:30 a.m. Sydney 👉 https://t.co/FajwkvebvA
#oncoalert #gynonc
0
8
20
#Editorial Lymphadenectomy in patients with advanced #ovariancancer undergoing IDS does not confer a prognostic benefit 🔎 https://t.co/7bfVZsi4a0
@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4
0
8
26
Deje de ser P… y asuma Sus complicaciones! Un popurrí de experiencias de los expertos de Latinoamérica! #dareymake #Medellín 2024 @RParejaGineOnco @danielsanabrias @Magaly_gineonco @drjuliolau @reitanribeiro @isla_david
0
2
6